The Effect of Novel Proprietary Test Formulation for Immunomodulatory activity by Assessing the CD Biomarkers and Colon Microscopy in TNBS-induced Ulcerative Colitis (UC) Rats Model

Dublin Core

Title

The Effect of Novel Proprietary Test Formulation for Immunomodulatory activity by Assessing the CD Biomarkers and Colon Microscopy in TNBS-induced Ulcerative Colitis (UC) Rats Model

Subject

Health & Wellness

Description

The aim of the present study was to evaluate the immunomodulatory action of Biofield Energy Healing (the Trivedi Effect®) Treatment to the animals and to the novel proprietary test formulation in tri-nitro benzene sulphonic acid (TNBS)-induced male Sprague Dawley rats. The test formulation consists of minerals (zinc, magnesium, iron, and copper) and vitamins (B6, B12, and D3). Each ingredient of the test formulation was divided into two parts. One part was denoted as the control without any Biofield Energy Healing Treatment, while the other part was defined as the Biofield Energy Treated sample, which received the Biofield Energy Healing Treatment by a renowned Biofield Energy Healer, Mr. Mahendra Kumar Trivedi. Additionally, three group of animals were also received Biofield Energy Treatment per se under similar conditions. The cellular biomarkers like cluster of differentiation-4 (CD4+), CD8+, and CD28+, biochemistry and hematology along with histopathologic profile were evaluated. The percentage of CD4+ count was increased by 8.87% in the G6 (Biofield Energy Treatment per se at day-15) group as compared to the untreated test formulation (G4) group. While the expression of CD8+ count was increased by 10.12% and 13.01% in the G6 and G7 (Biofield Energy Treated test formulation at day -15) groups, respectively as compared with the disease control (G2) group. Moreover, the level of CD28+ was significantly (p≤0.001) increased by 15.50% in the G5 (Biofield Energy Treated test formulation) group compared to the G2 group. In hematological analysis, platelet count was increased in the G7 by 8% compared with the G4. The level of uric acid was decreased by 40.47%, 13.8%, and 14.28% in the G6, G8 (Biofield Energy Treatment per se to animals plus Biofield Energy Treated test formulation at -15 day), and G9 (Biofield Energy Treatment per se to animals plus untreated test formulation) groups, respectively as compared with the G4 group. Histopathologic findings of all the tested groups did not show any abnormal findings with respect to the safe and nontoxic treatment strategies, which indicated that, the test formulation and Biofield Energy Treatment per se ameliorates colon inflammation in the TNBS-induced colitis rats by decreasing histopathologic lesions. Overall, the experimental data concluded that the Biofield Energy Treated test formulation showed considerable improved cellular and humoral immune response as compared with the untreated test formulation. Thus, the Trivedi Effect®-Biofield Energy Healing Treatment per se and the test formulation considerable improved cellular immune response, immunomodulatory effect, and gut health function.

Creator

Trivedi MK and Jana S

Source

[no text]

Publisher

Medwin Publishers

Date

5-Mar-2021

Contributor

[no text]

Rights

[no text]

Relation

[no text]

Format

[no text]

Language

English

Type

Journal Article

Identifier

[no text]

Coverage

[no text]

Citation

Trivedi MK and Jana S , “The Effect of Novel Proprietary Test Formulation for Immunomodulatory activity by Assessing the CD Biomarkers and Colon Microscopy in TNBS-induced Ulcerative Colitis (UC) Rats Model,” Mahendra Trivedi, accessed April 28, 2024, https://mahendratrivedi.omeka.net/items/show/469.